Chemoinformaics analysis of 1,3,5,8-tetrahydroxy xanthone
Molecular Weight | 328.32 | nRot | 2 |
Heavy Atom Molecular Weight | 312.192 | nRig | 18 |
Exact Molecular Weight | 328.095 | nRing | 3 |
Solubility: LogS | -3.159 | nHRing | 1 |
Solubility: LogP | 4.379 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
nHA | 6 | APOL | 45.5407 |
nHD | 4 | BPOL | 18.6553 |
QED | 0.326 |
Synth | 2.935 |
Natural Product Likeliness | 2.27 |
NR-PPAR-gamma | 0.968 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.013 |
Pgp-sub | 0.135 |
HIA | 0.058 |
CACO-2 | -4.976 |
MDCK | 0.00000947 |
BBB | 0.004 |
PPB | 0.917089 |
VDSS | 0.663 |
FU | 0.11491 |
CYP1A2-inh | 0.912 |
CYP1A2-sub | 0.276 |
CYP2c19-inh | 0.265 |
CYP2c19-sub | 0.054 |
CYP2c9-inh | 0.739 |
CYP2c9-sub | 0.794 |
CYP2d6-inh | 0.501 |
CYP2d6-sub | 0.203 |
CYP3a4-inh | 0.105 |
CYP3a4-sub | 0.05 |
CL | 6.901 |
T12 | 0.798 |
hERG | 0.003 |
Ames | 0.708 |
ROA | 0.216 |
SkinSen | 0.905 |
Carcinogencity | 0.236 |
EI | 0.908 |
Respiratory | 0.131 |
NR-Aromatase | 0.815 |
Antiviral | Yes |
Prediction | 0.78769 |